FindTrial
Sign In

Effect of Arjuna (Terminalia Arjuna) in disease due to improper venous drainage

Effect of Arjuna (Terminalia arjuna) in Chronic venous diseaseââ?¬â?? A prospective case series

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/028851
Enrollment
20
Registered
2020-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I832- Varicose veins of lower extremities with both ulcer and inflammation Health Condition 2: I838- Varicose veins of lower extremities with other complications

Interventions

Intervention1: Arjuna: Arjuna (Terminalia arjuna) tab with daily dosage of 1000 mg for 90 days Control Intervention1: Not Applicable: Not applicable

Sponsors

National Ayurveda Research Institute for Panchakarma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed CVD with clinical class C1-C6 (CEAP classification)

Exclusion criteria

Exclusion criteria: <18 years, CVD associated with uncontrolled diabetes, pregnant status

Design outcomes

Primary

MeasureTime frame
Venous clinical severity score Timepoint: Assessment will be done on 30th, 60th, 90th day and after 6 months.—

Secondary

MeasureTime frame
Chronic Venous Disease QoL questionnaire Timepoint: Assessment will be done on 30th, 60th, 90th day and after 6 months.—

Countries

India

Contacts

Public ContactPratap Shankar K M

CCRAS

kmpvarma@gmail.com09744824014

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026